In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People Round-Up: Appointments at Angelini, Polpharma, GSK, EMA, Holland & Barrett and Blackmores

Executive Summary

Angelini, Holland & Barrett and Blackmores have new CEOs, while GSK, Polpharma and the EMA have made executive appointments.

You may also be interested in...



GSK Divests ThermaCare To Angelini

Italy's Angelini expects its acquisition of the ThermaCare pain-relief line to spur the company's European growth ambitions in the consumer healthcare market.

Romania’s OTC Market in 2018: Colds And Flu Epidemic Help Boost Sales By 14%

Romanian self-care industry association, RASCI, provides HBW Insight with an exclusive viewpoint on the country's OTC market in 2018. 

Poland Kick Starts 2019 With Three Rx-To-OTC Switches

Clotrimazole, pyrantel, and ciclopirox olamine have been switched from prescription-to-OTC status by Poland's national drug regulator.

Topics

Related Companies

UsernamePublicRestriction

Register

PS142283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel